Govcon Giants


Text 786-477-0477

Eli Lilly and Co Awarded $312.5M Contract For Procurement Of Monoclonal Antibody Therapeutic LY-CoV555

 In Contract Awards

Eli Lilly and Co., Indianapolis, Indiana, was awarded a $312,500,000 firm-fixed-price contract for procurement of monoclonal antibody therapeutic LY-CoV555. Bids were solicited via the internet with one received. Work will be performed in Indianapolis, Indiana, with an estimated completion date of June 30, 2021. Fiscal 2021 Coronavirus Aid, Relief, and Economic Security (CARES) Act funds in the amount of $312,500,000 were obligated at the time of the award. U.S. Army Contracting Command, Aberdeen Proving Ground, Maryland, is the contracting activity (W911QY-21-C-0016). (Awarded Oct. 27, 2020)

Eli Lilly and Company discovers, develops, manufactures, and sells pharmaceutical products for humans and animals. Company products are sold in countries around the world. Eli Lilly products include neuroscience, endocrine, anti-infectives, cardiovascular agents, oncology, and animal health products. (

Recommended Posts

Leave a Comment